Jens Kopatz

Title: Jens Kopatz: Innovator in Neurodegenerative Disease Treatment

Introduction

Jens Kopatz is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of neurodegenerative and neuroinflammatory diseases. His innovative work has led to the development of a unique polysialic acid formulation that holds promise for therapeutic applications.

Latest Patents

Jens Kopatz holds a patent for "Polysialic acid and use for treatment of neurodegenerative and neuroinflammatory diseases." This invention relates to a branched or unbranched free or glycosidically bound polysialic acid, represented by the general formula (1). The polysialic acid is characterized by poly-(α(2→8 or 2→9)Neu5Ac)(1), where Neu5Ac is N-acetylneuraminic acid, and n is an integer ranging from 14 to 26. This invention also includes pharmaceutically acceptable salts and a polysaccharide composition comprising the polysialic acid. The application of this invention is particularly relevant in the therapeutic and prophylactic treatment of degenerative, demyelinating, and inflammatory diseases of the central nervous system, as well as degenerative or inflammatory retinal diseases.

Career Highlights

Throughout his career, Jens Kopatz has been associated with prestigious institutions such as Rheinische Friedrich-Wilhelms-Universität Bonn and Universität zu Köln. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Jens Kopatz has collaborated with notable colleagues, including Harald Neumann and Anahita Shahraz. These collaborations have enriched his research and expanded the impact of his inventions.

Conclusion

Jens Kopatz is a distinguished inventor whose work in polysialic acid has the potential to revolutionize the treatment of neurodegenerative diseases. His contributions to science and medicine continue to inspire future innovations.